Literature DB >> 24350959

Cystatin C versus creatinine for kidney function-based risk.

Michael G Shlipak, Josef Coresh, Ron T Gansevoort.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24350959     DOI： 10.1056/NEJMc1312801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.

Authors:  Anne Jacobs; Carolien Benraad; Jack Wetzels; Marcel Olde Rikkert; Cornelis Kramers
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

2.  [Decline in renal function in old age : Part of physiological aging versus age-related disease].

Authors:  F Braun; P T Brinkkötter
Journal:  Z Gerontol Geriatr       Date:  2016-07-25       Impact factor: 1.281

3.  Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.

Authors:  Angela Rosenbohm; Gabriele Nagel; Raphael S Peter; Torben Brehme; Wolfgang Koenig; Luc Dupuis; Dietrich Rothenbacher; Albert C Ludolph
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

4.  Protein intake in infancy and kidney size and function at the age of 6 years: The Generation R Study.

Authors:  Trudy Voortman; Hanneke Bakker; Sanaz Sedaghat; Jessica C Kiefte-de Jong; Albert Hofman; Vincent W V Jaddoe; Oscar H Franco; Edith H van den Hooven
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

5.  Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Kiang Liu; Laura A Colangelo; Martha L Daviglus; David C Goff; Mark Pletcher; Pamela J Schreiner; Christopher T Sibley; Gregory L Burke; Wendy S Post; Erin D Michos; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

6.  Use of cystatin C to inform metformin eligibility among adult veterans with diabetes.

Authors:  Delphine S Tuot; Rebecca Scherzer; Howard Leong; Adriana M Hung; Carl Grunfeld; Michael G Shlipak
Journal:  J Clin Transl Endocrinol       Date:  2016-03

7.  Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.

Authors:  Junqiang Pan; Xifeng Sun; Pengjie Zhang; Haichao Chen; Jing Lin
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

8.  Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.

Authors:  Delphine S Tuot; Feng Lin; Michael G Shlipak; Vanessa Grubbs; Chi-yuan Hsu; Jerry Yee; Vahakn Shahinian; Rajiv Saran; Sharon Saydah; Desmond E Williams; Neil R Powe
Journal:  Diabetes Care       Date:  2015-08-25       Impact factor: 19.112

Review 9.  Acute kidney injury and hepatorenal syndrome in cirrhosis.

Authors:  Kapil Gupta; Abhishek Bhurwal; Cindy Law; Scott Ventre; Carlos D Minacapelli; Savan Kabaria; You Li; Christopher Tait; Carolyn Catalano; Vinod K Rustgi
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.